Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study

References

• Aanouz, I., Belhassan, A., El-Khatabi, K., Lakhlifi, T., El-Ldrissi, M., & Bouachrine, M. (2020). Moroccan  Medicinal plants as inhibitors against SARS-CoV-2  main protease: Computational investigations. Journal of Biomolecular  Structure and Dynamics, 6, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1758790
   Google Scholar
• Adeoye, A. O., Oso, B. J., Olaoye, I. F., Tijjani, H., & Adebayo, A. I. (2020). Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1765876
   Google Scholar
• Al-Khafaji, K., Al-Duhaidahawil, D., & Tok, T. T. (2020). Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1764392
   Google Scholar
• Andrew, J., & Ben, L. (2011). Adaptive stochastic methods for sampling driven molecular systems. Journal of Chemical Physics, 135, 084125. https://doi.org/https://doi.org/10.1063/1.3626941
   PubMed Web of Science ®Google Scholar
• Bacha, U., Barrila, J., Velazquez-Campoy, A., Leavitt, S. A., & Freire, E. (2004). Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. Biochemistry, 43(17), 4906–4912. https://doi.org/https://doi.org/10.1021/bi0361766
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., Di Nola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/https://doi.org/10.1063/1.448118
   Web of Science ®Google Scholar
• Bolcato, G., Bissaro, M., Pavan, M., Sturlese, M., & Moro, S. (2020). Targeting the Coronavirus SARS-CoV-2: Computational insights into the mechanism of action of the protease inhibitors Lopinavir, Ritonavir and Nelfinavir. Researchsquare. https://doi.org/https://doi.org/10.21203/rs.3.rs-20948/v1
   Google Scholar
• Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1758788
   Google Scholar
• Case, D. A., Babin, V., Berryman, J. T., Betz, R. M., Cai, Q., Cerutti, D. S., Cheatham, T. E., Darden, T. A., Duke, R. E., Gohlke, H., Goetz, A. W., Gusarov, S., Homeyer, N., Janowski, P., Kaus, J., Kolossváry, I., Kovalenko, A., Lee, T. S., Le Grand, S., … Kollman, P. A. (2014). AMBER 14. University of California.
   Google Scholar
• Chen, L. R., Wang, Y. C., Lin, Y. W., Chou, S. Y., Chen, S. F., Liu, L. T., Wu, Y. T., Kuo, C. J., Chen, T. S. S., & Juang, S. H. (2005). Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors. Bioorganic & Medicinal Chemistry Letters, 15(12), 3058–3062. https://doi.org/https://doi.org/10.1016/j.bmcl.2005.04.027
   PubMed Web of Science ®Google Scholar
• Daniel, R. R., & Cheatham, T. E. (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. https://doi.org/https://doi.org/10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Das, S., Sarmah, S., Lyndem, S., & Roy, A. S. (2020). An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1763201
   Google Scholar
• Dassault Systems BIOVIA. (2017). Discovery studio modeling environment, release. Dassault Systems BIOVIA.
   Google Scholar
• Delano, W. L. (2002). PyMol molecular graphics system. Delano Scientific.
   Google Scholar
• Elfiky, A. (2020). A SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silico perspective. Journal of Biomolecular Structure and Dynamics, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1761882
   Google Scholar
• Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T., & Yelekçi, K. (2020). Drug repurposing for coronavirus (COVID-19): Insilico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1758791
   Google Scholar
• Enmozhi, S. K., Raja, K., Sebastine, I., & Joseph, J. (2020). Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach. Journal of Biomolecular Structure and Dynamics, 1–7. https://doi.org/https://doi.org/10.1080/07391102.2020.1760136
   Google Scholar
• Fenghua, W., Cheng, C., Wenjie, T., Kailin, Y., & Haitao, Y. (2016). Structure of main protease from human coronavirus NL63: Insights for wide spectrum anti-coronavirus drug design. Scientific Reports, 6, 22677. https://doi.org/https://doi.org/10.1038/srep22677
   PubMed Web of Science ®Google Scholar
• Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Montgomery, Jr., J. A., Vreven, T., Kudin, K. N., Burant, J. C., Millam, J. M., Iyengar, S. S., Tomasi, J., Barone, V., Mennucci, B., Cossi, M., Scalmani, G., Rega, N., Petersson, G. A., … Pople, J. A. (2004). Gaussian, Inc., Wallingford CT. Gaussian 03, Revision C. 02. Gaussian.
   Google Scholar
• Glenn, J. M., Adam, H., & Tuckerman, M. E. (1999). Molecular dynamics algorithms for path integrals at constant pressure. The Journal of Chemical Physics, 110(7), 3275–3290. https://doi.org/https://doi.org/10.1063/1.478193
   Web of Science ®Google Scholar
• Gyebi, G. A., Ogunro, O. B., Adegunloye, A. P., Ogunyemi, O. M., & Afolabi, S. O. (2020). Potential Inhibitors of Coronavirus 3-Chymotrypsin-Like Protease (3CLpro): An in silico screening of Alkaloids and Terpenoids from African medicinal plants. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1764868
   Web of Science ®Google Scholar
• Hossam, M. A., Walid, F E M., Masudur, R., & Hatem, A E. (2020). Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks. Pathogens, 9(186), 1–15. https://doi.org/https://doi.org/10.3390/pathogens9030186
   Google Scholar
• https://clinicaltrials.gov/ct2/show/NCT00838162.
   Google Scholar
• https://clinicaltrials.gov/ct2/show/NCT03110549.
   Google Scholar
• https://www.the-scientist.com/news-opinion/flu-and-anti-hiv-drugs-show-efficacyagainstcoronavirus-67052.
   Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD-Visual Molecular Dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/https://doi.org/10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M. A., & Halim, M. A. (2020). A. molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1–12. https://doi.org/https://doi.org/10.1080/07391102.2020.1761883
   Google Scholar
• Jacobson, M. P., Pincus, D. L., Rapp, C. S., Day, T. J. F., Honig, B., Shaw, D. E., & Friesner, R. A. (2004). A hierarchical approach to all-atom protein loop prediction. Proteins, 55(2), 351–367. https://doi.org/https://doi.org/10.1002/prot.10613
   PubMed Web of Science ®Google Scholar
• Jinzi, J., Wu, B. R. S., Milot, G., Ge, M., Dandache, S., Forte, A., Pelletier, I., Dubois, A., Belanger, O., & Panchal, C. (2006, September 27–30). Pl-100, a next generation protease inhibitor against drug-resistant HIV: In vitro & in vivo metabolism. In 46th Annual ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francosco, CA.
   Google Scholar
• Joshi, R. S., Jagdale, S. S., Bansode, S. B., Shankar, S. S., Tellis, M. B., Pandya, V. K., Chugh, A., Giri, A. P., & Kulkarni, M. J. (2020). Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. Journal of Biomolecular Structure and Dynamics, 1–16. https://doi.org/https://doi.org/10.1080/07391102.2020.1760137
   Google Scholar
• Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1753577
   Google Scholar
• Khan, S. A., Zia, K., Uddin, S. A. R., & Ul-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1751298
   Google Scholar
• Kumar, D., Kumari, K., Jayaraj, A., Kumar, V., Kumar, R. V., Dass, S. K., Chandra, R., & Singh, P. (2020). Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1752310
   Google Scholar
• Linlin, Z., Daizong, L., Xinyuanyuan, S., Ute, C., Christian, D., Lucie, S., Stephan, B., Katharina, R., & Rolf, H. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science, 368 (6489), 409–412. https://doi.org/https://doi.org/10.1126/science.abb3405.
   Google Scholar
• Li-Sheng, W., Yi-Ru, W., Da-Wei, Y., & Qing-Quan, L. (2020). A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence. International Journal of Antimicrobial Agents, 55 (6), 105948. https://doi.org/https://doi.org/10.1016/j.ijantimicag.2020
   Google Scholar
• Lobo-Galo, N., Terrazas-López, M., Martínez-Martínez, A., & Díaz-Sánchez, A. G. (2020). FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication. Journal of Biomolecular Structure and Dynamics, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1764393
   Google Scholar
• Lv, Z., Chu, Y., & Wang, Y. (2015). HIV protease inhibitors: A review of molecularselectivity and toxicity. HIV/AIDS - Research and Palliative Care, 7, 95–104.
   Google Scholar
• Minah, P., Alex, R. C., Jue, T. L., Yinxiaohe, S., & Borame, L. D. (2020). A Systematic Review of COVID-19 Epidemiology Based on Current Evidence. Journal of Clinical Medicine, 9, 967. https://doi.org/https://doi.org/10.3390/jcm9040967
   Web of Science ®Google Scholar
• Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. Journal of Biomolecular Structure and Dynamics, 1–6. https://doi.org/https://doi.org/10.1080/07391102.2020.1752802
   Google Scholar
• Onufriev, A., Bashford, D., & Case, D. A. (2000). Modification of the generalized born model suitable for macromolecules. The Journal of Physical Chemistry B, 104(15), 3712–3720. https://doi.org/https://doi.org/10.1021/jp994072s
   Web of Science ®Google Scholar
• Pant, S., Singh, M., Ravichandiran, V., Murty, U. S. N., & Srivastava, H. K. (2020). Peptide-like and small-molecule inhibitors against Covid-19. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1757510
   Google Scholar
• Parr, R. G., & Yang, W. (1989). Density functional theory of atoms and molecules. Oxford.
   Google Scholar
• Stellbrink, H. J., Arastéh, K., Schürmann, D., Stephan, C., Dierynck, I., Smyej, I., Hoetelmans, R. M. W., Truyers, C., Meyvisch, P., Jacquemyn, B., Mariën, K., Simmen, K., & Verloes, R. (2014). Antiviral activity, pharmacokinetics, and safety of the HIV-1 Protease Inhibitor TMC310911, coadministered with ritonavir, in treatment-naive HIV-1-infected patients ). JAIDS Journal of Acquired Immune Deficiency Syndromes, 65(3), 283–289. https://doi.org/https://doi.org/10.1097/QAI.0000000000000003
   PubMed Web of Science ®Google Scholar
• Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C. K., Zhou, J., Liu, W., Bi, Y., & Gao, G., F. (2016). Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends in Microbiology, 24(6), 490–502. https://doi.org/https://doi.org/10.1016/j.tim.2016.03.003
   PubMed Web of Science ®Google Scholar
• Tang, B., Bragazzi, N. L., Li, Q., Tang, S., Xiao, Y., & Wu, J. (2020). An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infectious Disease Modelling, 5, 248–255. https://doi.org/https://doi.org/10.1016/j.idm.2020.02.001
   PubMedGoogle Scholar
• Umesh, K., D., Selvaraj, C., Singh, S. K., & Dubey, V. K. (2020). Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target. Journal of Biomolecular Structure and Dynamics, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1763202
   Google Scholar
• Wahedi, H. M., Ahmad, S., & Abbasi, S. W. (2020). Stilbene-based natural compounds as promising drug candidates against COVID-19. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1762743
   Google Scholar
• Xiaoyu, X., Hongwei, Y., Haitao, Y., Fei, X., Zhixin, W., Wei, S., Jun, L., Zhe, Z., Yi, D., Qi, Z., Xuejun, C. Z., Ming, L., Mark, B., & Zihe, R. (2008). Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design. Journal of Virology, 82(5), 2515–2527. https://doi.org/https://doi.org/10.1128/JVI.02114-07
   PubMed Web of Science ®Google Scholar
• Yamamoto, N., Matsuyama, S., & Hoshino, T. (2020). Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro. bioRxiv. https://doi.org/https://doi.org/10.1101/2020.04.06.026476
   Google Scholar
• Yamamoto, N., Yang, R., Yoshinaka, Y., Amari, S., Nakano, T., Cinatl, J., Rabenau, H., Doerr, H. W., Hunsmann, G., Otaka, A., Tamamura, H., Fujii, N., & Yamamoto, N. (2004). HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochemical and Biophysical Research Communications, 318(3), 719–725.
   PubMed Web of Science ®Google Scholar
• Zhou, L., Liu, Y., Zhang, W., Wei, P., Huang, C., Pei, J., Yuan, Y., & Lai, L. (2006). Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors. Journal of Medicinal Chemistry, 49(12), 3440–3443. https://doi.org/https://doi.org/10.1021/jm0602357
   PubMed Web of Science ®Google Scholar
• Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/https://doi.org/10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar